Monday, Fox news reported that "The experimental drug used to treat two American aid workers who have been infected with the Ebola virus
has never been tested on humans before and was only identified earlier
this year as part of an ongoing research program backed by the U.S. government and military."
Fox also said, "The Defense Department has long had a hand in
researching infectious diseases, including Ebola. During much of the
Cold War period this served two purposes: to keep abreast of diseases
that could limit the effectiveness of troops deployed abroad and to be
prepared if biological agents were used as weapons." It was also stated
that the U.S. military currently has no biological weapons program.
But not to worry, a new player has entered the ring. It seems that Monsanto
and the DOD have teamed up to invest in an Ebola virus treatment
company. Monsanto, the company that has given us Agent Orange, Roundup
pesticide, and GMO food, is now working to give us an Ebola vaccine.
What is Monsanto's gain one must ask. The deal is, the seed money
Monsanto will contribute begins at $1.5 million. The value of the deal
has the potential to grow to an estimated $86 million dollars. The
company’s name is Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a
leading developer of RNA interference (RNAi) therapeutics. “TKM-Ebola,
an anti-Ebola virus RNAi therapeutic, is being developed under a $140
million contract with the U.S. Department of Defense’s Medical
Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product
Management Office”. That's a pretty sweet deal by anyone's calculations.
READ MORE: http://www.examiner.com/article/monsanto-bed-with-dod-over-ebola-can-t-be-good